Form 4: Unity Biotechnology Director Acquires Stock Options

Nathaniel E. David, a director at Unity Biotechnology, acquired stock options for 10,000 shares of common stock on June 21, 2024.

Summary

• On June 21, 2024, Nathaniel E. David, a director of Unity Biotechnology, Inc. (UBX), acquired stock options.
• The stock options grant the right to buy 10,000 shares of Unity Biotechnology's common stock at an exercise price of $1.38 per share.
• The options vest and become exercisable on the earlier of June 21, 2025, or the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.
• The options expire on June 20, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock option grant. The positive aspect is the director's increased stake in the company, but it's not a major event.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the vesting of the options is contingent on continued service as a director.

Industry Context

This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in the biotechnology industry as a form of compensation and incentive.
• The vesting schedule of one year or until the next annual meeting is fairly standard.
• Comparing the exercise price to the current market price of UBX would provide further context on the potential value of these options.

Stakeholder Impact

• Shareholders may view the director's acquisition of stock options as a positive sign, aligning the director's interests with those of the shareholders.

Key Dates